Vladimir M Pogorelov PharmD

Associate Research Scientist in Psychiatry

Psychiatry: Connecticut Mental Health Center

B.S., State Medical University - Moscow, Russia, 1990
M.Sc., State Medical University - Moscow, Russia, 1990
Ph.D., Institute of Pharmacology at the Russian Academy of Medical Sciences, 1999
Pharm.D., Russian Academy of Medical Sciences, 1999

V.M. Pogorelov, J. Nomura, J. Kim, G. Kannan, Y. Ayhan, C. Yang, Y. Taniguchi, B. Abazyan, H. Valentine, I.N. Krasnova, A. Kamiya, J.-L. Cadet, D.F. Wong, M.V. Pletnikov. Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model. Neuropharmacology 2011, PMID: 21315744.
K.V. Savelieva, S. Zhao, V.M. Pogorelov, I. Rajan, E. Cullinan, Q. Yang, T.H. Lanthorn. Genetic disruption of both Tryptophan Hydroxylase genes strongly reduces serotonin in the brain and affects behavior in models sensitive to antidepressants. Plos One 2008, 3(10): e3301.
S.S. Mason, K.B. Baker, K.W. Davis, V.M. Pogorelov, M.M. Malbari, R. Ritter, S.P. Wray, B. Gerhardt, T.H. Lanthorn, K.V. Savelieva. Differential sensitivity to SSRI and tricyclic antidepressants in juvenile and adult mice of three strains. Eur J Pharmacol 2009, 602: 306-315.